054670 — Daehan New Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual balance sheet for Daehan New Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17,233	20,360	21,494	28,550	22,960
Net Total Accounts Receivable
Net Total Receivables	34,817	31,592	32,189	37,569	40,331
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	66,130	68,702	76,033	102,641	98,485
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	30,876	38,570	46,294	46,978	54,313
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	127,906	132,733	157,643	169,359	176,927
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	49,703	51,119	45,049	58,584	61,758
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	66,840	73,494	75,178	66,400	67,571
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	61,066	59,239	82,465	102,959	109,356
Total Liabilities & Shareholders' Equity	127,906	132,733	157,643	169,359	176,927
Total Common Shares Outstanding